Speaker

Michael Weickert

Chief Executive Officer, Pacylex Pharmaceuticals

Michael Weickert, Chief Executive Officer at Pacylex Pharmaceuticals, is speaking at 3rd ADC Payload Summit (Boston, United States of America, 4–6 Nov 2026) in the session “Unlocking NMT Inhibitors as a Novel ADC Payload Class Beyond Conventional Cytotoxic Mechanisms”.

Conferences: 1
Keynotes: 0
Upcoming: 1

Pharmacy & Pharmaceutical Sciences

Upcoming appearances

3rd ADC Payload Summit
4–6 Nov 2026Boston, United States of America
- SpeakerUnlocking NMT Inhibitors as a Novel ADC Payload Class Beyond Conventional Cytotoxic Mechanisms

More speakers at 3rd ADC Payload Summit

Robert Lutz
Chief Scientific Officer, Iksuda Therapeutics
Dori Thomas-Karyat
Chief Executive Officer, Synthis Therapeutics
Vicky Appleman
Director, Oncology Drug Discovery, Takeda
Tara Arvedson
Chief Scientific Officer, Hexagon Bio
Prajna Behera
Senior Principal Scientist, Oncology Innovation, GlaxoSmithKline
Krzysztof Brzózka
Chief Scientific Officer, Ryvu Therapeutics

See all 16 speakers on the event page

This profile is built from conference programmes published on kongre.net. It has not been claimed or confirmed by Michael Weickert, and it lists only the talks, sessions and presentations named in those programmes.

Is this you? Claim this profile — every request is read by a person before anything is linked.

To ask for a correction or for this profile to be removed, email [email protected].